Systemic L-ornithine supplementation specifically increases ovarian putrescine levels during ovulation in mice†

Biol Reprod. 2022 Apr 26;106(4):792-801. doi: 10.1093/biolre/ioab233.

Abstract

In all mammalian species examined thus far, the ovaries produce a burst of ornithine decarboxylase (ODC) and putrescine during ovulation or after application of human chorionic gonadotropin (hCG). Aged mice have significantly reduced levels of this periovulatory ODC and putrescine rise. Putrescine supplementation, in vitro during oocyte maturation or in mouse drinking water during the periovulatory period, reduces egg aneuploidies and embryo resorption, improving fertility of aged mice. These studies suggest that periovulatory putrescine supplementation may be a simple and effective therapy for reproductive aging for women. However, putrescine supplementation is expected to increase widespread tissue putrescine levels, raising concerns of nonspecific and unwanted side effects. Given that ODC is highly expressed in the ovaries during ovulation but otherwise exhibits low activity in most tissues, we hypothesized that periovulatory supplementation of L-ornithine, the substrate of ODC, might be suitable for delivering putrescine specifically to the ovaries. In this study, we have demonstrated that systemic application of L-ornithine via oral gavage or subcutaneous injection increased ovarian putrescine levels; the increase was restricted to animals that had been injected with hCG. Furthermore, L-ornithine specifically increased ovarian putrescine levels without affecting putrescine levels in any other tissues. However, our attempts to improve fertility of aged mice through L-ornithine supplementation in mouse drinking water produced either no effects (1% L-ornithine) or negative impact on fertility (4% ornithine). Our results suggest that it might not be feasible to achieve fertility-enhancing ovarian putrescine levels via L-ornithine supplementation in drinking water without encountering undesired consequences of high dose of exogenous L-ornithine.

Keywords: Infertility; L-ornithine; aging; ornithine decarboxylase; ovaries; putrescine.

MeSH terms

  • Animals
  • Chorionic Gonadotropin / pharmacology
  • Dietary Supplements*
  • Drinking Water
  • Female
  • Humans
  • Mice
  • Ornithine Decarboxylase / pharmacology
  • Ornithine* / pharmacology
  • Ovary
  • Ovulation
  • Putrescine* / pharmacology

Substances

  • Chorionic Gonadotropin
  • Drinking Water
  • Ornithine
  • Ornithine Decarboxylase
  • Putrescine